Personal experience with the detection of platelet factor 4 using radioimmunoanalysis
Pecka, M.; Malý, J.; Simsa, J.; Siroký, O.; Bláha, M.; Jebavý, L.
Vnitrni Lekarstvi 30(6): 557-562
1984
ISSN/ISBN: 0042-773X PMID: 6474861 Document Number: 240224
Document emailed within 1 workday
Related Documents
Hirschman, R.J.; Gralnick, H.R. 1974: A simplified platelet factor 3 (PF-3) assay for the rapid detection of platelet isoantibodies and an antiplatelet factor in ATP and SLE Journal of Laboratory and Clinical Medicine 84(2): 292-297Pombo, L.; Ruibal, A.; Soriano, A.; Duque, J.J.; Fombellida, J.C. 1988: Behavior of CEA MARIA (monoclonal antibody radioimmunoanalysis in the serum of patients with non-tumorous diseases. Comparison with polyclonal radioimmunoanalysis Revista Clinica Espanola 183(7): 383-384
Toupalík, P.; Stefan, J. 1994: Personal experience with detection of myoglobin in the myocardium using the immunoperoxidase method Soudni Lekarstvi 39(4): 39-43
Seguchi, M.; Nakajima, S. 1995: Induction of ICAM-1 expression on the eosinophilic leukemia cell line-3 (EoL-3) by platelet-activating factor and platelet factor 4 Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 74(3): 255-257
Wygledowska-Promieńska, D.; Zawojska, I. 2000: Procedure for keratoconus detection according to the Rabinowitz-Rasheed method--personal experience Klinika Oczna 102(4): 241-244
Hegyi, E.; Nakeff, A. 1989: Ultrastructural localization of platelet factor 4 in rat megakaryocytes and platelets by gold-labeled antibody detection Experimental Hematology 17(3): 223-228
Hwang, S.B.; Li, C.L.; Lam, M.H.; Shen, T.Y. 1985: Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist Laboratory Investigation; a Journal of Technical Methods and Pathology 52(6): 617-630
Issekutz, A.C.; Szpejda, M. 1986: Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988 Laboratory Investigation; a Journal of Technical Methods and Pathology 54(3): 275-281
Floch, A.; Tahraoui, L.; Sedivy, P.; Cavero, I. 1991: The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes Journal of Pharmacology and Experimental Therapeutics 258(2): 567-575
Andresen, J.L.; Ehlers, N. 1998: Chemotaxis of human keratocytes is increased by platelet-derived growth factor-BB, epidermal growth factor, transforming growth factor-alpha, acidic fibroblast growth factor, insulin-like growth factor-I, and transforming growth factor-beta Current Eye Research 17(1): 79-87
Holt, J.C.; Niewiarowski, S. 1989: Platelet basic protein, low-affinity platelet factor 4, and beta-thromboglobulin: purification and identification Methods in Enzymology 169: 224-233
Macpherson, J.L.; Kemp, A.; Rogers, M.; Mallet, A.I.; Toia, R.F.; Spur, B.; Earl, J.W.; Chesterman, C.N.; Krilis, S.A. 1989: Occurrence of platelet-activating factor (PAF) and an endogenous inhibitor of platelet aggregation in diffuse cutaneous mastocytosis Clinical and Experimental Immunology 77(3): 391-396
Macchi, L.; Clofent-Sanchez, G.; Marit, G.; Bihour, C.; Durrieu-Jais, C.; Besse, P.; Nurden, P.; Nurden, A.T. 1996: PAICA: a method for characterizing platelet-associated antibodies--its application to the study of idiopathic thrombocytopenic purpura and to the detection of platelet-bound c7E3 Thrombosis and Haemostasis 76(6): 1020-1029
Rizzino, A.; Kazakoff, P.; Ruff, E.; Kuszynski, C.; Nebelsick, J. 1988: Regulatory effects of cell density on the binding of transforming growth factor beta, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor Cancer Research 48(15): 4266-4271
Reed, G.L.; Matsueda, G.R.; Haber, E.; Haber, E. 1992: Platelet factor XIIi increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha 2-antiplasmin to fibrin Thrombosis and Haemostasis 68(3): 315-320
Pfueller, S.L.; Howard, M.A.; White, J.G.; Menon, C.; Berry, E.W. 1987: Shortening of bleeding time by 1-deamino-8-arginine vasopressin (DDAVP) in the absence of platelet von Willebrand factor in Gray platelet syndrome Thrombosis and Haemostasis 58(4): 1060-1063
Ishioka, S.; Saito, T.; Hiyama, K.; Haruta, Y.; Maeda, A.; Hozawa, S.; Inamizu, T.; Yamakido, M. 1996: Increased expression of tumor necrosis factor-alpha, interleukin-6, platelet-derived growth factor-B and granulocyte-macrophage colony-stimulating factor mRNA in cells of bronchoalveolar lavage fluids from patients with sarcoidosis Sarcoidosis Vasculitis and Diffuse Lung Diseases: Official Journal of Wasog 13(2): 139-145
Gereliuk, I.P.; Stukal, I.V. 1991: Disorders of plasma lipid spectrum, lysoform levels of platelet activating factor and blood platelet sensitivity to adrenaline in patients with stable stress-induced stenocardia Kardiologiia 31(1): 82-83
Ionescu, C.; Berindan-Neagoe, I.; Burz, C.; Balacescu, O.; Balacescu, L.; Tudoran, O.; Asztalos, R.; Irimie, A. 2011: The clinical implications of platelet derived growth factor B, vascular endothelial growth factor and basic fibroblast growth factor in colorectal cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 16(2): 274-276
Kara, I.Oguz.; Sahin, B.; Gunesacar, R.; Unsal, C. 2006: Clinical significance of hepatocyte growth factor, platelet-derived growth factor-AB, and transforming growth factor-alpha in bone marrow and peripheral blood of patients with multiple myeloma Advances in Therapy 23(4): 635-645